Boston Scientific News
Most Popular Boston Scientific Story
Stent advances expected to prop up European market
First, the bad news: The overall European coronary stent market is expected to dip to about $490 million by 2016, even with growth in procedure numbers. That market number will be the result of a Read more >>
Latest Headlines
- January 19, 2012
- January 5, 2012
- December 19, 2011
- December 19, 2011
- December 12, 2011
- November 30, 2011
- November 23, 2011
- November 21, 2011
- October 17, 2011
- October 10, 2011
- September 30, 2011
- September 21, 2011
- September 19, 2011
- September 13, 2011
- August 8, 2011
- August 1, 2011
- June 7, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
